rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    GNPX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Genprex presents data linking gene therapy to cellular maintenance
      Nov 5Investing.comGNPX
      Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress
      Nov 5Yahoo FinanceGNPX
      Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer
      Nov 4Yahoo FinanceGNPX
      Genprex highlights preclinical study on TUSC2 gene in brain aging
      Oct 21Investing.comGNPX
      Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
      Oct 21Yahoo FinanceGNPX
      Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference

      Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), today announced that members of its executive leadership team will present at and participate in the H.C. Wainwright 28th Annual Global Investment Conference, being held September 14–16 in New York City. Genprex is a clinical-stage biotechnology company developing gene therapies designed to restore tumor-suppressor function in cancer and insulin-producing function in diabetes. The Company's lead oncology program is in clinical developmen

      Sep 8Yahoo FinanceGNPX
      Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program

      Andelyn Biosciences, a leading contract development and manufacturing organization, announced today that Genprex, Inc. has selected Andelyn to support scale-up manufacturing for its diabetes gene therapy program.

      Sep 1Yahoo FinanceGNPX

      This is the newest page. Registered accounts read further back.